GIM
TTOO

Granahan Investment Management’s T2 Biosystems, Inc TTOO Stock Holding History

Granahan Investment Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-62
Closed -$202K – 207
2020
Q1 		$202K Sell
62
-2
-3% -$8.31K 0.01% 183
2019
Q4 		$374K Buy
64
+20
+45% +$189K 0.02% 170
2019
Q3 		$544K Buy
+44
New +$353K 0.03% 169

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Granahan Investment Management's TTOO Position: Q2 2020 in Review

Granahan Investment Management sold out of T2 Biosystems, Inc (TTOO) in Q2 2020, closing a stake of 62 shares — an estimated $202K sold.

Granahan Investment Management first reported a position in TTOO in Q3 2019 and held it in 3 quarters. The position peaked at $544K in Q3 2019. 46 funds tracked by Wall St. Rank hold TTOO as of Q2 2020.

  • Granahan Investment Management reported no remaining T2 Biosystems, Inc position as of Q2 2020 after selling out during the quarter.
  • Granahan Investment Management sold 62 T2 Biosystems, Inc shares in Q2 2020, an estimated $202K.
  • Granahan Investment Management first reported a position in T2 Biosystems, Inc in Q3 2019 and held it in 3 quarters.
  • Granahan Investment Management's T2 Biosystems, Inc position peaked at $544K in Q3 2019.
  • 46 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2020.

Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.